Study held to see the effect of Dashamuladi tablet in Amavata (rheumatoid arthritis)

A single arm clinical study to evaluate the efficacy of Dashamuladi ghana vati in Amavata

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037955

Enrollment

Registered

2021-11-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients with the signs and symptoms of Amavata.- Shoola(pain) in joint Shotha(swelling) in joints Stambha(stiffness) in joints Lakhnas of ama –agnimandya(anorexia), angamardana(body ache), Trushna( thirst), Alasya( laziness), Gaurav( haviness). 2)Above mentioned 3 and more than 3 symptoms.

Exclusion criteria

Exclusion criteria: 1)chronicity for more than 10 years. 2)having severe crippling deformity. 3)having cardiac diseases, TB. 4)steroid dependent for the relief of symptoms.

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of Dashamuladi Ghana Vati in reduction of shoola(pain) in Amavata.(By vas scale) Timepoint: 21 days study(0,7,14,21 days)	—

Secondary

Measure	Time frame
To study the new etiological factor in the present era, if any. Timepoint: 21 days study(0,7,14,21 days)	—

Countries

India

Contacts

Public ContactShweta Sonaji Kodre

Dr. D.Y.Patil college of Ayurveda and research Centre

vjayu82@gmail.com8983478062

Outcome results